ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO442

Managed Care Program Improves Hospitalization Rate in ESKD Patients

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Walker, Adam G., Davita Clinical Research, Minneapolis, Minnesota, United States
  • Sibbel, Scott, Davita Clinical Research, Minneapolis, Minnesota, United States
  • Marlowe, Gilbert, Davita Clinical Research, Minneapolis, Minnesota, United States
  • Roer, David A., DaVita Inc, Denver, Colorado, United States
  • Tentori, Francesca, Davita Clinical Research, Minneapolis, Minnesota, United States
  • Brunelli, Steven M., Davita Clinical Research, Minneapolis, Minnesota, United States
Background

Care fragmentation, a lack of coordinated care for patients, is associated with reduced quality of care, increased costs, and poor clinical outcomes. End stage kidney disease (ESKD) patients are at increased risk of care fragmentation due to the complex collection of conditions that often accompany ESKD (i.e., diabetes, hypertension, etc.) and require care from multiple healthcare providers. Recently, managed care programs have started to defragment care for ESKD patients through collaboration across healthcare organizations in order to improve clinical outcomes. However, whether and to what degree these programs are effective is unknown.

Methods

This was a retrospective, observational study of dialysis patients with commercial or Medicare Advantage insurance treating with a dialysis provider in the United States from June 2021- June 2022. The primary exposure was enrollment in a managed care program. Expected hospitalization rates for enrolled patients were estimated by indirect standardization versus the non-enrolled patients.

Results

After accounting for differences in age, comorbidities, insurance type, and geography, we observed that enrolled patients had 0.11 admits per-patient per-year favorable hospitalization rate compared to non-enrolled patients. This resulted in an estimated 961 hospitalizations prevented among approximately 8,500 enrolled patients during the study period. Hospitalization reduction was similar between managed care programs done in partnership with government and private insurers.

Conclusion

A provider managed integrated kidney care program can be effective in improving clinical outcomes for ESKD patients for public or private payors.